23 April 2019 - - US-based pharmaceutical companies Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) have received top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg, the company said.
The objective o...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
23 April 2019 - - The US Food and Drug Administration has approved abbreviated new drug application No. 208024 for Fluticasone Propionate Nasal Spray USP, 50 mcg per spray owned by Akorn, Inc. (NASDAQ: AKRX), US-based emerging commercial-stage pharma...
23 April 2019 - - Chinese biotechnology company HitGen Inc has achieved a milestone in its discovery alliance with US-based drugmaker Merck and Co. Inc., the company said.
The milestone was for the identification of candidates meeting pr...
The milestone was for the identification of candidates meeting pr...
23 April 2019 - - US-based biopharmaceutical company Arrakis Therapeutics has completed a USD 75m series B financing co-led by venBio Partners and Nextech Invest, with participation by new investors Omega Funds, HBM Healthcare Investments, GV (former...
23 April 2019 - - US-based clinical-stage immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has appointed Stanford Peng, M.D. Ph.D as president and head of research and development of Alpine, the company said.
Peng, who s...
Peng, who s...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe